Offering sells units of common shares, two-year warrants at C$0.15
By Devika Patel
Knoxville, Tenn., June 11 - Medifocus Inc. said it raised C$2.76 million in the first tranche of a private placement of units, which will now raise C$6.09 million. The deal priced for C$2 million on March 16 and was subsequently oversubscribed and increased to C$7 million on May 22. The company expects to close on a second tranche for C$3.33 million.
The company is now selling 40,567,253 units of one common share and one warrant at C$0.15 per unit. It sold 18,367,253 units in the first tranche and expects to sell 22.2 million units in the second tranche.
The warrants are each exercisable at C$0.20 for two years. The strike price is identical to the May 21 closing share price.
Proceeds will be used primarily for working capital and to continue the phase III clinical trials of Medifocus Microfocus APA 1000 System to treat breast cancer.
The Burlington, Ont., company is developing minimally invasive, focused-heat tumor-targeted cancer treatment devices and systems.
| Issuer: | Medifocus Inc.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | C$6,085,088
|
| Units: | 40,567,253
|
| Price: | C$0.15
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Two years
|
| Warrant strike price: | C$0.20
|
| Pricing date: | March 16
|
| Revised: | May 22, June 11
|
| Settlement date: | June 11 (for C$2,755,088)
|
| Stock symbol: | TSX Venture: MFS
|
| Stock price: | C$0.20 at close May 21
|
| Market capitalization: | C$6.84 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
